This year's flu vaccine guards against new strains

by Lauran Neergaard

(AP)—Time to get your flu vaccine. And remember: Last year's shot won't protect you this year.

said Thursday that this year's vaccine contains protection against two different that have begun circling the globe. And just because flu was mild last winter, doesn't mean it won't bounce back with its usual ferocity this winter.

With 135 million doses expected, there's plenty of vaccine to go around.

Flu vaccination is recommended for virtually everyone older than 6 months of age. But the government says just 42 percent of Americans were immunized last year.

The good news is that three-quarters of babies and toddlers were vaccinated. But even though people 65 and older also are at very high risk, just two-thirds were vaccinated.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Is a repeat flu shot needed? This fall, maybe not

May 27, 2011

(AP) -- Vaccine makers said this month they plan to make a record amount of flu vaccine for this fall and winter - enough for more than half the population. It's just not clear all those people will need ...

Time to get your flu shot, but just one this year

Aug 31, 2010

(AP) -- It's flu-shot season already, and for the first time health authorities are urging nearly everyone to get vaccinated. There is even a new high-dose version for people 65 or older.

Recommended for you

EU regulator: Morning-after pill OK for all women

5 hours ago

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

9 hours ago

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Zydelig approved for three types of blood cancer

10 hours ago

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Journal raises concern about blood-thinning drug

23 hours ago

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

User comments